A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation
J. Magenau, P. Westervelt, S. Khaled, J. McGuirk, P. Hari, M. Eapen, P. S. Becker, B. Parkin, T. Braun, B. Logan, H. Wang, M. Jagasia, S. D. Rowley, D. D.H. Kim, T. Schechter, N. Frey, B. Scott, T. Churay, S. Lieland, S. FormanS. Mineishi
Dive into the research topics of 'A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation'. Together they form a unique fingerprint.